SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-031174
Filing Date
2021-06-01
Accepted
2021-06-01 16:30:33
Documents
5
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A odt-def14a_20210624.htm DEF 14A 1534091
2 GRAPHIC gpp4rm1oezsp000003.jpg GRAPHIC 71045
3 GRAPHIC gpp4rm1oezsp000004.jpg GRAPHIC 203347
4 GRAPHIC gpp4rm1oezsp000001.jpg GRAPHIC 11126
5 GRAPHIC gpp4rm1oezsp000002.jpg GRAPHIC 11126
  Complete submission text file 0001564590-21-031174.txt   1944207
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38318 | Film No.: 21985732
SIC: 2834 Pharmaceutical Preparations